The global HER-2 negative breast cancer market is estimated to be valued at US$ 12,647.0 million in 2022 and is expected to exhibit a CAGR of 10.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
HER-2 negative breast cancer refers to a type of breast cancer that does not overexpress HER-2 protein. It accounts for a significant portion of breast cancer cases globally. The market ... Read more
